Immunosuppressive Agents

DBCAT000047Therapeutic categoryL04A

Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. A DrugBank category of 340 drugs. 275 of them are approved.

ATC classification: L — ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L04 — IMMUNOSUPPRESSANTS
L04A — IMMUNOSUPPRESSANTS
Also known as: Immunosuppressants · Agents, Immunosuppressive · Immunosuppressant drugs
Drugs: 2-Methoxyethanol
9-(N-methyl-L-isoleucine)-cyclosporin A
Abatacept
Abetimus
Acazicolcept
Acteoside
Adalimumab
Afelimomab
Alclometasone
Aldesleukin
Aldosterone
Alefacept
Alemtuzumab
Altretamine
Amcinonide
Amsacrine
Anakinra
Anifrolumab
Antilymphocyte immunoglobulin (horse)
Antithymocyte immunoglobulin (rabbit)
Apremilast
Arsenic trioxide
Atacicept
Avacincaptad pegol
Avacopan
and 315 more with a free account

What you can answer from here — as of May 21, 2021

340DrugsEach linked to its full drug card

414Drug targetsEvery drug–target pair in the class, with bond type

44,385Marketed productsAcross the regions we cover, with dosage forms and routes

56Routes of administrationHow the drugs in this class are given

5SubcategoriesNarrower classes within this one

Which targets do Immunosuppressive Agents share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account